AXIN2 and glioblastoma: We showed that HECTD1 negatively regulates canonical WNT activity in GBM cells similar to USP15, as determined by reporter assay or measuring expression of the prototypic WNT target gene AXIN2. Modulation of HECTD1 expression pheno-copied the effects of USP15 in GBM cells.